Covid-19 Vaccine Responsiveness in MM and Waldenstrom

CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

NCT01995708 ·Status: COMPLETED ·Phase: PHASE1

CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig

NCT03383055 ·Status: COMPLETED ·Phase: PHASE1

Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients

NCT05164016 ·Status: COMPLETED

Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant

NCT01852591 ·Status: COMPLETED ·Phase: NA

Immune Response to the COVID-19 Vaccine

NCT04936997 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer

NCT00001582 ·Status: COMPLETED

Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma

NCT00965224 ·Status: COMPLETED ·Phase: PHASE2

Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally

NCT00083538 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands

NCT02203825 ·Status: COMPLETED ·Phase: PHASE1

Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection

NCT04362865 ·Status: COMPLETED

Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System

NCT00001158 ·Status: COMPLETED

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

NCT03207854 ·Status: RECRUITING

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

NCT04952766 ·Status: COMPLETED ·Phase: PHASE4

Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients

NCT01394640 ·Status: COMPLETED

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

NCT06089967 ·Status: COMPLETED

Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer

NCT02018458 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma

NCT00937183 ·Status: COMPLETED ·Phase: NA

Host Immune Response to Novel RNA COVID-19 Vaccination

NCT04784689 ·Status: COMPLETED

Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma

NCT00683670 ·Status: COMPLETED ·Phase: PHASE1

COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics

NCT04871932 ·Status: RECRUITING

Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

NCT05228275 ·Status: ACTIVE_NOT_RECRUITING

Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

NCT00988312 ·Status: COMPLETED ·Phase: PHASE1

Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission

NCT01686334 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

NCT04948619 ·Status: RECRUITING ·Phase: PHASE2

Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12

NCT00622401 ·Status: TERMINATED ·Phase: PHASE1/PHASE2